跳至主要内容
临床试验/NL-OMON56269
NL-OMON56269已完成不适用

Effects of 10 gram collagen protein hydrolysate on cardiometabolic health in obese (BMI 25-35 kg/m2) men and women with elevated risk to develop Type-2 diabetes and CVD - Collagen peptides and glycemic control

Voeding en Bewegingswetenschappen0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Aged between 40-75 years - Men and women - BMI between 25-35 kg/m2 - Serum
  • total cholesterol < 8.0 mmol/L (further testing is recommended for excessive
  • hyperlipidemia [serum total cholesterol >= 8.0 mmol/L] according to the Standard
  • for cardiovascular risk management of the Dutch general practitioners community
  • [NHG]) - Serum triacylglycerol < 4.5 mmol/L - No current smoker - No
  • diabetic patients - No familial hypercholesterolemia - No abuse of drugs - Not
  • more than 4 alcoholic consumption per day with a maximum of 21 per week?? -
  • Stable body weight (weight gain or loss < 3 kg in the past three months) -
  • No use of medication known to treat blood pressure, lipid or glucose metabolism
  • - No use of an investigational product within another biomedical intervention
  • in the previous month - No severe medical conditions that might interfere with
  • the study, such as epilepsy, asthma, kidney failure or renal insufficiency,
  • chronic obstructive pulmonary disease, inflammatory bowel diseases, auto
  • inflammatory diseases and rheumatoid arthritis - No active cardiovascular
  • disease like congestive heart failure or cardiovascular event, such as an acute
  • myocardial infarction or cerebrovascular accident - Willingness to give up
  • being a blood donor from 8 weeks before the start of the study, during the
  • study and for 4 weeks after completion of the study - No difficult venipuncture
  • as evidenced during the screening visit - Willing to comply to study protocol
  • during study - Agree to take porcine / animal derived supplements (i.e.
  • collagen) - Informed consent signed

排除标准

  • - Allergy or intolerance to collagen or collagen hydrolysates - Serum total
  • cholesterol >= 8.0 mmol/L - Serum triacylglycerol >= 4.5 mmol/L - Current smoker,
  • or smoking cessation <12 months - Diabetic patients - Familial
  • hypercholesterolemia - Abuse of drugs - More than 4 alcoholic consumptions per
  • day or 21 per week - Unstable body weight (weight gain or loss > 3 kg in the
  • past three months) - Use medication known to treat blood pressure, lipid or
  • glucose metabolism - Use of an investigational product in another biomedical
  • intervention within the previous month - Severe medical conditions that might
  • interfere with the study, such as epilepsy, asthma, kidney failure or renal
  • insufficiency, chronic obstructive pulmonary disease, inflammatory bowel
  • diseases, auto inflammatory diseases and rheumatoid arthritis - Active
  • cardiovascular disease like congestive heart failure or cardiovascular event,
  • such as an acute myocardial infarction or cerebrovascular accident - Not
  • willing to give up being a blood donor from 8 weeks before the start of the
  • study, during the study or for 4 weeks after completion of the study - Not or
  • difficult to venipuncture as evidenced during the screening visit - Use of
  • over-the-counter and prescribed medication or supplements, which may interfere
  • with study measurements to be judged by the principal investigator; - Use of
  • oral antibiotics in 40 days or less prior to the start of the study; - Blood
  • donation in the past 3 months before the start of the study - Not willing to
  • comply to study protocol during study or sign informed consent - Not willing to
  • consume the collagen hydrolysate because this is from animal origin

研究者

发起方
Voeding en Bewegingswetenschappen

相似试验